This activity is expired and is no longer available for CME credit.


MS Forum

Author(s)/Faculty: Fred D. Lublin, MD, FAAN, FANA; Patricia K. Coyle, MD, FAAN; Bruce A. Cohen, MD; Anne H. Cross, MD; Ilana Katz-Sand, MD
Release Date: 12/19/2014Expiration Date: 12/18/2015
Credit Type: CME / CNENumber of Credits: 0
Content Type: MultimediaProvider:
Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disease of the central nervous system that primarily affects the myelin sheath, axonal integrity, and neuronal signal transduction. Left unmanaged, MS can lead to significant limitations and disability. However, disease progression can be significantly reduced by optimizing the use of current and emerging disease-modifying therapies. Because patients initially present with variable, nondescript features, it may be difficult for clinicians to obtain an early diagnosis upon evaluation. Moreover, due to the lack of commonly accepted treatment algorithms, disease management options are usually driven by patient preference and provider experience rather than evidence-based medicine. In this program, leading neurologists will discuss validated methods for accurate differential diagnosis and evaluation, analyze evidence surrounding the use of current treatment options, provide techniques to increase patient compliance with treatment regimens, and engage in a comparative dialogue regarding emerging therapeutics and their role in personalized medicine.